Export

EN
FR
ATC codes: J04BA01
EMLc
Indication
Multi-drug resistant Mycobacterium tuberculosis ICD11 code: ML32.00
INN
Clofazimine
Medicine type
Chemical agent
List type
Complementary (EML)
(EMLc)
Additional notes
Reserve second-line drugs for the treatment of multidrug-resistant tuberculosis (MDR-TB) should be used in specialized centres adhering to WHO standards for TB control.
Formulations
Oral > Solid: 100 mg ; 50 mg
EML status history
First added in 2017 (TRS 1006)
Changed in 2019 (TRS 1021)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Wikipedia
DrugBank
Summary of evidence and Expert Committee recommendations
The Expert Committee recommended an amendment to the dosage form terminology for clofazimine, replacing 'capsule' with 'solid oral dosage form'.